Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute and Post DM senior resident at AIIMS, New Delhi, posted the following on X:
“The 10-year results of FOWARC published in JCO ASCO today.
- No difference in DFS, LR, and OS between 5FU-RT, FOLFOX-RT, and FOLFOX alone for LA rectal cancer
- Second study after PROSPECT questioning the role of RT
- More LAR syndrome and persistent ostomy in CRT compared to chemo alone.”